Health behaviors among unaffected participants following receipt of variants of uncertain significance in cardiomyopathy-associated genes

被引:3
|
作者
Miller, Ilana M. [1 ]
Lewis, Katie L. [1 ]
Lawal, Tokunbor A. [1 ,3 ]
Ng, David [1 ]
Johnston, Jennifer J. [1 ]
Biesecker, Barbara B. [2 ,4 ]
Biesecker, Leslie G. [1 ]
机构
[1] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA
[2] NHGRI, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA
[3] NINR, Tissue Injury Branch, NIH, Bethesda, MD 20892 USA
[4] Res Triangle Inst, Raleigh, NC USA
关键词
Health behaviors; Healthcare use; Genome sequencing; Psychological reactions; Variants of uncertain significance; UNKNOWN SIGNIFICANCE; RISK PERCEPTION; BRCA2; VARIANTS; CANCER; IMPACT; WOMEN; DECISIONS; WORRY;
D O I
10.1038/s41436-018-0083-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Studies on returning variants of uncertain significance (VUS) results have predominantly included patients with a personal or family history of cancer and cancer-associated gene VUS. This study examined health behaviors among participants with cardiomyopathy-associated gene VUS, but without a personal history of cardiomyopathy. Methods: Sixty-eight eligible participants without apparent cardiomyopathy but with VUS in cardiomyopathy-associated genes completed a survey of health behaviors, disclosure, distress, uncertainty, positive experiences, decisional conflict, and perceived value. The medical records of participants who reported cardiac testing because of their VUS were reviewed for testing indication(s). Results: Two participants had cardiac testing due to their VUS alone. Four had cardiac testing because of their VUS and other clinical indications. Twelve changed health behaviors, including one participant who was subsequently diagnosed with cardiomyopathy. Distress, uncertainty, and decisional conflict were low (means = 1.2, 4.2, and 24.5 (scale ranges = 0-30, 0-45, and 15-75), respectively), and positive experiences and perceived value were moderate (means = 12.4 and 14.4 (scale ranges = 0-20 and 4-20), respectively). Greater perceived value was associated with greater likelihood to engage in health behaviors (P = 0.04). Conclusion: Positive VUS results can be returned to apparently unaffected individuals with modest use of healthcare resources, minimal behavioral changes, and favorable psychological reactions.
引用
收藏
页码:748 / 752
页数:5
相关论文
共 29 条
  • [1] Health behaviors among unaffected participants following receipt of variants of uncertain significance in cardiomyopathy-associated genes Response
    Mendelsohn, Bryce A.
    Sabbadini, Marta
    GENETICS IN MEDICINE, 2019, 21 (03) : 762 - 762
  • [2] Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Myocarditis
    Tiron, Coloma
    Campuzano, Oscar
    Fernandez-Falgueras, Anna
    Alcalde, Mireia
    Loma-Osorio, Pablo
    Zamora, Elisabet
    Caballero, Angel
    Sarquella-Brugada, Georgia
    Cesar, Sergi
    Garcia-Cuenllas, Luisa
    Garcia-Alvarez, Ana
    Jorda, Paloma
    Arbelo, Elena
    Tomas-Querol, Carlos
    Pineda, Victor
    Martinez, Daniel
    Brugada, Ramon
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2022, 15 (03): : E003408
  • [3] Predicting Disease Risk Among Variants in Cardiomyopathy-Associated Genes Across Diverse Genetic Ancestries
    Wolfe, Rachel
    Gurumoorthi, Manasa
    Chahal, Anwar
    Dabbagh, Ghaith Sharaf
    Landstrom, Andrew
    CIRCULATION, 2024, 150
  • [4] A Precision Medicine Approach to Predicting Pathogenicity Among Population Variants in Hypertrophic Cardiomyopathy-Associated Genes in the UK Biobank
    Kurzlechner, Leonie M.
    Bair, Courtney
    Monaco, Gabrielle
    Gurumoorthi, Manasa
    Dabbagh, Ghaith Sharaf
    Kishnani, Sujata
    Tadros, Hanna J.
    Shah, Ravi
    Patel, Viraj
    CIRCULATION, 2023, 148
  • [5] Determining the Likelihood of Disease Pathogenicity Among Incidentally Identified Genetic Variants in Rare Dilated Cardiomyopathy-Associated Genes
    Yang, Qixin
    Berkman, Amy M.
    Ezekian, Jordan E.
    Rosamilia, Michael
    Rosenfeld, Jill A.
    Liu, Pengfei
    Landstrom, Andrew P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (19):
  • [6] Prevalence of Pathogenic Variants in Dilated Cardiomyopathy-Associated Genes in Patients Evaluated for Cardiac Sarcoidosis
    Reza, Nosheen
    Levin, Michael
    Vidula, Mahesh K.
    Bravo, Paco E.
    Damrauer, Scott M.
    Ritchie, Marylyn
    Chahal, Anwar A.
    Owens, Anjali T.
    CIRCULATION, 2022, 146
  • [7] Prevalence of Pathogenic Variants in Dilated Cardiomyopathy-Associated Genes in Patients Evaluated for Cardiac Sarcoidosis
    Reza, Nosheen G.
    Levin, Michael K.
    Vidula, Mahesh E.
    Bravo, Paco M.
    Damrauer, Scott D.
    Ritchie, Marylyn
    Regeneron Genetics Ctr, Anjali Tiku
    Chahal, C. Anwar A.
    Owens, Anjali Tiku
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2023, 16 (04): : 409 - 411
  • [8] CLINICAL PHENOTYPES ASSOCIATED WITH POTENTIALLY PATHOLOGIC VARIANTS IN CARDIOMYOPATHY-ASSOCIATED GENES IN A LARGE ELECTRONIC MEDICAL RECORD
    Triana, Taylor Suzanne
    Farber-Eger, Eric
    Wang, Thomas
    Roden, Dan
    Wells, Quinn
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A955 - A955
  • [9] Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants
    Shah, Ravi A.
    Asatryan, Babken
    Dabbagh, Ghaith Sharaf
    Aung, Nay
    Khanji, Mohammed Y.
    Lopes, Luis R.
    van Duijvenboden, Stefan
    Holmes, Anthony
    Muser, Daniele
    Landstrom, Andrew P.
    Lee, Aaron Mark
    Arora, Pankaj
    Semsarian, Christopher
    Somers, Virend K.
    Owens, Anjali T.
    Munroe, Patricia B.
    Petersen, Steffen E.
    Chahal, C. Anwar A.
    CIRCULATION, 2022, 146 (02) : 110 - 124
  • [10] Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis A Systematic Review and Meta-Analysis
    Monda, Emanuele
    Bakalakos, Athanasios
    Cannie, Douglas
    'Mahony, Constantinos
    Syrris, Petros
    Kaski, Juan Pablo
    Limongelli, Giuseppe
    Elliott, Perry Mark
    JACC-HEART FAILURE, 2023, 12 (06) : 1101 - 1111